Equities

Centessa Pharmaceuticals PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Centessa Pharmaceuticals PLC

Actions
  • Price (EUR)20.60
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change+28.75%
  • Beta1.5631
Data delayed at least 15 minutes, as of Feb 18 2026 08:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, Centessa Pharmaceuticals PLC increased its cash reserves by 199.32%, or 255.19m. Cash Flow from Financing totalled 364.75m or -- of revenues. In addition the company used 142.06m for operations while cash from investing totalled 31.27m.
Cash flow per share-1.81
Price/Cash flow per share--
Book value per share2.24
Tangible book value per share2.24
More ▼

Balance sheet in USDView more

Centessa Pharmaceuticals PLC appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio10.57
Quick ratio--
Total debt/total equity0.3641
Total debt/total capital0.2669
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.